Halozyme Therapeutics Inc
HALO
NASDAQ
Biotechnology
$98.66
USD
-2.01 (-2.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $11.43B
Volume 1.7M
Price Target
$115.00 – $115.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $115.00 and a min estimate of $115.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$115.00
+$26.8 vs prior
Implied Upside
+16.6%
+27.1% vs prior
Analyst Covering
1
-3 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
20%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Mitchell S. Kapoor | HC Wainwright & Co. | Buy | Maintained | 1 week ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
SMMT
Summit Therapeutics Inc
$13.35
▼ -4.6%
APGE
Apogee Therapeutics Inc
$134.55
▲ +0.1%
BMRN
BioMarin Pharmaceutical Inc
$67.36
▼ -1.7%
ARWR
Arrowhead Pharmaceuticals Inc
$86.64
▲ +1.2%
PRAX
Praxis Precision Medicines Inc
$366.81
▼ -0.5%
PTGX
Protagonist Therapeutics Inc
$155.10
▲ +2.4%
EXEL
Exelixis Inc
$51.24
▲ +1.2%
CYTK
Cytokinetics Inc
$74.13
▲ +0.9%
MDGL
Madrigal Pharmaceuticals Inc
$507.56
▲ +0.0%